Back to Search
MATTHEW KOZLOFF, M.D.
M.D.
Surgery Physician
NPI: 1801933288Individual
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
C55616(CA)ME108087(FL)40482(KY)
Surgical Critical Care Physician
Surgery — Surgical Critical Care
Code: 2086S0102X
40482(KY)
Trauma Surgery Physician
Surgery — Trauma Surgery
Code: 2086S0127X
MD12565(RI)40482(KY)
Research & Publications (13)
Phase II study of sunitinib malate in head and neck squamous cell carcinoma.
PMID 19649772·Invest New Drugs·2010
3-trial
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
PMID 19201650·Lancet Oncol·2009
3-trial
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE).
PMID 18854571·J Clin Oncol·2008
4-observational
A phase II study of ABT-751 in patients with advanced non-small cell lung cancer.
PMID 18520803·J Thorac Oncol·2008
3-trial
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
PMID 18758303·J Thorac Oncol·2008
3-trial
Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer.
PMID 17409864·J Thorac Oncol·2006
3-trial
Thoracoscopic application of a topical sealant for the management of persistent posttraumatic pneumothorax.
PMID 16456444·J Trauma·2006
8-other
Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer.
PMID 16615097·Cancer·2006
3-trial
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
PMID 16258101·J Clin Oncol·2005
3-trial
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.
PMID 15297392·Clin Cancer Res·2004
3-trial
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer.
PMID 15020613·J Clin Oncol·2004
3-trial
Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP).
PMID 15337569·Int J Radiat Oncol Biol Phys·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 838 NORDAHL ROAD, SUITE 270
SAN MARCOS, CA 92069 - Phone
- (760) 489-5955
Quick Facts
- NPI
- 1801933288
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 6
- Locations
- 1
- Publications
- 13
Are you this provider?
Claim Your Profile